First Header Logo Second Header Logo

Connection

Steven Feldman to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Treatment Outcome.
Steven Feldman
Connection Strength
7.846
Treatment Outcome
  1. Dawn AG, Balkrishnan R, Feldman SR. Systematic selection bias: a cause of dramatic errors in the inference of treatment effectiveness. J Dermatolog Treat. 2008; 19(2):68-71.
    View in: PubMed
    Score: 0.174
  2. Emmerich VK, Purvis CG, Feldman SR. An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne. Expert Opin Pharmacother. 2021 Sep; 22(13):1661-1667.
    View in: PubMed
    Score: 0.110
  3. Bell KA, Balogh EA, Feldman SR. An update on the impact of depression on the treatment of psoriasis. Expert Opin Pharmacother. 2021 Apr; 22(6):695-703.
    View in: PubMed
    Score: 0.106
  4. Svoboda SA, Ghamrawi RI, Owusu DA, Feldman SR. Treatment Goals in Psoriasis: Which Outcomes Matter Most? Am J Clin Dermatol. 2020 Aug; 21(4):505-511.
    View in: PubMed
    Score: 0.104
  5. Gadarowski MB, Ghamrawi RI, Taylor SL, Feldman SR. PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines. Ann Pharmacother. 2021 03; 55(3):354-361.
    View in: PubMed
    Score: 0.104
  6. Stein Gold LF, Takiya L, Zang C, Sanders P, Feldman SR. Demographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis. J Drugs Dermatol. 2020 Jun 01; 19(6):619-624.
    View in: PubMed
    Score: 0.103
  7. Bashyam AM, Cuellar-Barboza A, Masicampo EJ, Feldman SR. Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use. J Am Acad Dermatol. 2020 Dec; 83(6):1773-1775.
    View in: PubMed
    Score: 0.102
  8. Ramachandran V, Bertus B, Bashyam AM, Feldman SR. Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2020 09; 54(9):872-878.
    View in: PubMed
    Score: 0.101
  9. Howell AN, Ghamrawi RI, Strowd LC, Feldman SR. Pharmacological management of atopic dermatitis in the elderly. Expert Opin Pharmacother. 2020 May; 21(7):761-771.
    View in: PubMed
    Score: 0.101
  10. Okwundu N, Cardwell LA, Cline AE, Richardson IM, Feldman SR. Adherence to topical treatment can improve treatment-resistant moderate psoriasis. Cutis. 2020 Feb; 105(2):89-91;E2;E3.
    View in: PubMed
    Score: 0.100
  11. Bashyam AM, Cuellar-Barboza A, Ghamrawi RI, Feldman SR. Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis. J Am Acad Dermatol. 2020 Sep; 83(3):944-946.
    View in: PubMed
    Score: 0.100
  12. Feldman SR, Zhang J, Martinez DJ, Lopez-Gonzalez L, Marchlewicz EH, Shrady G, Mendelsohn AM, Zhao Y. Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status. J Dermatolog Treat. 2021 Mar; 32(2):203-211.
    View in: PubMed
    Score: 0.099
  13. Li W, Ghamrawi R, Haidari W, Feldman SR. Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis. Ann Pharmacother. 2020 04; 54(4):380-387.
    View in: PubMed
    Score: 0.099
  14. Jackson DG, Cardwell LA, Oussedik E, Feldman SR. Utility of boron in dermatology. J Dermatolog Treat. 2020 Feb; 31(1):2-12.
    View in: PubMed
    Score: 0.098
  15. Okwundu N, Cline A, Feldman SR. Difference in vasoconstrictors: oxymetazoline vs. brimonidine. J Dermatolog Treat. 2021 Mar; 32(2):137-143.
    View in: PubMed
    Score: 0.097
  16. Payne J, Habet KA, Pona A, Feldman SR. A Review of Topical Corticosteroid Foams J Drugs Dermatol. 2019 Aug 01; 18(8):756-770.
    View in: PubMed
    Score: 0.097
  17. Hall SL, Haidari W, Feldman SR. Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab J Drugs Dermatol. 2019 Aug 01; 18(8):822-823.
    View in: PubMed
    Score: 0.097
  18. Bray JK, Johnson MC, Masicampo EJ, Feldman SR. Optimizing presentation of expected treatment outcomes. J Am Acad Dermatol. 2020 Aug; 83(2):602-604.
    View in: PubMed
    Score: 0.097
  19. Piccinin MA, Cline A, Feldman SR. Decreased phototherapy effectiveness on lower body. Dermatol Online J. 2019 Jun 15; 25(6).
    View in: PubMed
    Score: 0.096
  20. Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical Retinoids in Acne Vulgaris: A Systematic Review. Am J Clin Dermatol. 2019 Jun; 20(3):345-365.
    View in: PubMed
    Score: 0.096
  21. Okwundu N, Cardwell L, Cline A, Richardson I, Feldman SR. Is topical treatment effective for psoriasis in patients who failed topical treatment? J Dermatolog Treat. 2021 Feb; 32(1):41-44.
    View in: PubMed
    Score: 0.096
  22. Wu JJ, Lu M, Veverka KA, Smulders M, Papademetriou E, Yu J, Feldman SR. The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment. J Dermatolog Treat. 2019 Aug; 30(5):446-453.
    View in: PubMed
    Score: 0.093
  23. Kolli SS, Gabros SD, Pona A, Cline A, Feldman SR. Tildrakizumab: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2019 04; 53(4):413-418.
    View in: PubMed
    Score: 0.092
  24. Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019 Feb; 80(2):411-416.e4.
    View in: PubMed
    Score: 0.092
  25. Heath MS, Sahni DR, Curry ZA, Feldman SR. Pharmacokinetics of tazarotene and acitretin in psoriasis. Expert Opin Drug Metab Toxicol. 2018 Sep; 14(9):919-927.
    View in: PubMed
    Score: 0.091
  26. Okwundu N, Cardwell LA, Cline A, Unrue EL, Richardson IM, Feldman SR. Topical corticosteroids for treatment-resistant atopic dermatitis. Cutis. 2018 Sep; 102(3):205-209.
    View in: PubMed
    Score: 0.091
  27. Feldman SR, Zhao Y, Gilloteau I, Graham CN, Miles L, McBride D, Herrera V. Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study. J Manag Care Spec Pharm. 2018 Jul; 24(7):617-622.
    View in: PubMed
    Score: 0.090
  28. Patel NU, Gowda A, Grammenos A, Onikoyi O, Feldman SR. Six week evaluation of the potential for topical desoximetasone 0.25% spray to induce photoallergic skin reaction. J Dermatolog Treat. 2018 May; 29(3):269-271.
    View in: PubMed
    Score: 0.086
  29. Patel N, Nadkarni A, Cardwell LA, Vera N, Frey C, Patel N, Feldman SR. Psoriasis, Depression, and Inflammatory Overlap: A Review. Am J Clin Dermatol. 2017 Oct; 18(5):613-620.
    View in: PubMed
    Score: 0.085
  30. Oussedik E, Cardwell LA, Patel NU, Onikoyi O, Feldman SR. An Anchoring-Based Intervention to Increase Patient Willingness to Use Injectable Medication in Psoriasis. JAMA Dermatol. 2017 09 01; 153(9):932-934.
    View in: PubMed
    Score: 0.085
  31. Nadkarni A, Saleem MD, Feldman SR. Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization. J Drugs Dermatol. 2017 Aug 01; 16(8):755-758.
    View in: PubMed
    Score: 0.084
  32. Patel NU, D'Ambra V, Feldman SR. Increasing Adherence with Topical Agents for Atopic Dermatitis. Am J Clin Dermatol. 2017 Jun; 18(3):323-332.
    View in: PubMed
    Score: 0.083
  33. Saleem MD, Feldman SR. Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis. J Dermatolog Treat. 2018 Feb; 29(1):36-38.
    View in: PubMed
    Score: 0.083
  34. Saleem MD, Negus D, Feldman SR. Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial. J Dermatolog Treat. 2018 Feb; 29(1):32-35.
    View in: PubMed
    Score: 0.083
  35. Davis SA, Himmler S, Feldman SR. Cost-effectiveness analysis of using dermatologists versus pediatricians to treat mild to moderate acne. Dermatol Online J. 2017 May 15; 23(5).
    View in: PubMed
    Score: 0.083
  36. Vera N, Patel N, Cardwell LA, Saleem M, Feldman SR. Chemical pharmacotherapy options for managing adult acne. Expert Opin Pharmacother. 2017 Feb; 18(3):263-273.
    View in: PubMed
    Score: 0.081
  37. Bartos S, Hill D, Feldman SR. Review of maintenance of response to psoriasis treatments. J Dermatolog Treat. 2016 Aug; 27(4):293-7.
    View in: PubMed
    Score: 0.079
  38. Cline A, Hill D, Lewallen R, Feldman SR. Current status and future prospects for biologic treatments of psoriasis. Expert Rev Clin Immunol. 2016 Dec; 12(12):1273-1287.
    View in: PubMed
    Score: 0.078
  39. Hoffman MB, Hill D, Feldman SR. Current challenges and emerging drug delivery strategies for the treatment of psoriasis. Expert Opin Drug Deliv. 2016 Oct; 13(10):1461-73.
    View in: PubMed
    Score: 0.078
  40. Kin KC, Hill D, Feldman SR. Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis. Expert Rev Clin Pharmacol. 2016 Jun; 9(6):789-97.
    View in: PubMed
    Score: 0.078
  41. Feldman SR, Bushnell DM, Klekotka PA, Scanlon M, Martin ML, Wade SW, Yang W, Pinto L, Kircik L, Viswanathan HN. Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice. J Dermatolog Treat. 2016; 27(3):224-7.
    View in: PubMed
    Score: 0.074
  42. Farhangian ME, Feldman SR. Moving Away from Fee-for-Service: Implications for Medication Adherence. South Med J. 2015 May; 108(5):298-9.
    View in: PubMed
    Score: 0.072
  43. Anderson KL, Feldman SR. Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis. J Cutan Med Surg. 2015 Jul-Aug; 19(4):361-6.
    View in: PubMed
    Score: 0.071
  44. Sandoval LF, Huang KE, Harrison J, Clark A, Feldman SR. Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference. Cutis. 2014 Dec; 94(6):304-9.
    View in: PubMed
    Score: 0.070
  45. Feldman SR, Burudpakdee C, Gala S, Nanavaty M, Mallya UG. The economic burden of psoriasis: a systematic literature review. Expert Rev Pharmacoecon Outcomes Res. 2014 Oct; 14(5):685-705.
    View in: PubMed
    Score: 0.068
  46. Feldman SR, Huang WW, Huynh TT. Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease. J Manag Care Spec Pharm. 2014 Jun; 20(6):623-9.
    View in: PubMed
    Score: 0.068
  47. Huang KE, Carstensen SE, Feldman SR. The duration of acne treatment. J Drugs Dermatol. 2014 Jun; 13(6):655-6.
    View in: PubMed
    Score: 0.068
  48. Mauskopf J, Samuel M, McBride D, Mallya UG, Feldman SR. Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: a systematic review of published models and clinical practice guidelines. Pharmacoeconomics. 2014 Apr; 32(4):395-409.
    View in: PubMed
    Score: 0.067
  49. Sandoval LF, Semble A, Gustafson CJ, Huang KE, Levender MM, Feldman SR. Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients. J Drugs Dermatol. 2014 Feb; 13(2):135-40.
    View in: PubMed
    Score: 0.066
  50. Sandoval LF, Huang K, O'Neill JL, Gustafson CJ, Hix E, Harrison J, Clark A, Buxton OM, Feldman SR. Measure of atopic dermatitis disease severity using actigraphy. J Cutan Med Surg. 2014 Jan-Feb; 18(1):49-55.
    View in: PubMed
    Score: 0.066
  51. Feldman SR, Winkelman W, Baum E, Preston N. Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray. J Drugs Dermatol. 2013 Dec; 12(12):1456-60.
    View in: PubMed
    Score: 0.066
  52. Sandoval LF, Hartel JK, Feldman SR. Current and future evidence-based acne treatment: a review. Expert Opin Pharmacother. 2014 Feb; 15(2):173-92.
    View in: PubMed
    Score: 0.065
  53. Sandoval LF, Huang KE, Feldman SR. Adherence to ustekinumab in psoriasis patients. J Drugs Dermatol. 2013 Oct; 12(10):1090-2.
    View in: PubMed
    Score: 0.065
  54. Ahn CS, Gustafson CJ, Sandoval LF, Davis SA, Feldman SR. Cost effectiveness of biologic therapies for plaque psoriasis. Am J Clin Dermatol. 2013 Aug; 14(4):315-26.
    View in: PubMed
    Score: 0.064
  55. Akamine KL, Gustafson CJ, Yentzer BA, Edison BL, Green BA, Davis SA, Feldman SR. A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis. J Drugs Dermatol. 2013 Aug; 12(8):855-9.
    View in: PubMed
    Score: 0.064
  56. Feldman SR, Mills M, Brundage T, Eastman WJ. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp. J Drugs Dermatol. 2013 Mar; 12(3):300-6.
    View in: PubMed
    Score: 0.062
  57. Shah A, Yentzer BA, Feldman SR. Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies. Cutis. 2013 Feb; 91(2):105-7.
    View in: PubMed
    Score: 0.062
  58. Tripathi SV, Gustafson CJ, Huang KE, Feldman SR. Side effects of common acne treatments. Expert Opin Drug Saf. 2013 Jan; 12(1):39-51.
    View in: PubMed
    Score: 0.061
  59. Mudigonda T, Dabade TS, West CE, Feldman SR. Therapeutic modalities for localized psoriasis: 308-nm UVB excimer laser versus nontargeted phototherapy. Cutis. 2012 Sep; 90(3):149-54.
    View in: PubMed
    Score: 0.060
  60. Feldman SR, Matheson R, Bruce S, Grande K, Markowitz O, Kempers S, Brundage T, Wyres M. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials. Am J Clin Dermatol. 2012 Aug 01; 13(4):261-71.
    View in: PubMed
    Score: 0.060
  61. Feldman SR, Fried RG, Herndon JH, Johnson L, Preston N, Gottschalk RW, Caveney SW. Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris. J Drugs Dermatol. 2012 Aug; 11(8):919-25.
    View in: PubMed
    Score: 0.060
  62. Hagele TJ, Levender MM, Davis SA, Williford PM, Feldman SR. Practice trends in the treatment of actinic keratosis in the United States: 0.5% fluorouracil and combination cryotherapy plus fluorouracil are underused despite evidence of benefit. J Cutan Med Surg. 2012 Mar-Apr; 16(2):107-14.
    View in: PubMed
    Score: 0.058
  63. Barnes LE, Levender MM, Fleischer AB, Feldman SR. Quality of life measures for acne patients. Dermatol Clin. 2012 Apr; 30(2):293-300, ix.
    View in: PubMed
    Score: 0.057
  64. Glenn C, Feldman SR. Letter: Tetracycline-induced hepatotoxicity. Dermatol Online J. 2011 Dec 15; 17(12):14.
    View in: PubMed
    Score: 0.057
  65. Smith SF, Feldman SR. Tattoo sites and psoriasis. J Drugs Dermatol. 2011 Oct; 10(10):1199-200.
    View in: PubMed
    Score: 0.056
  66. Yentzer BA, Wood AA, Sagransky MJ, O'Neill JL, Clark AR, Williams LL, Feldman SR. An Internet-based survey and improvement of acne treatment outcomes. Arch Dermatol. 2011 Oct; 147(10):1223-4.
    View in: PubMed
    Score: 0.056
  67. Haushalter K, Murad EJ, Dabade TS, Rowell R, Pearce DJ, Feldman SR. Efficacy of low-dose acitretin in the treatment of psoriasis. J Dermatolog Treat. 2012 Dec; 23(6):400-3.
    View in: PubMed
    Score: 0.056
  68. Yentzer BA, Gosnell AL, Clark AR, Pearce DJ, Balkrishnan R, Camacho FT, Young TA, Fountain JM, Fleischer AB, Colón LE, Johnson LA, Preston N, Feldman SR. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. J Am Acad Dermatol. 2011 Apr; 64(4):793-5.
    View in: PubMed
    Score: 0.054
  69. Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011 May; 64(5):936-49.
    View in: PubMed
    Score: 0.054
  70. Rajpara AN, O'Neill JL, Nolan BV, Yentzer BA, Feldman SR. Review of home phototherapy. Dermatol Online J. 2010 Dec 15; 16(12):2.
    View in: PubMed
    Score: 0.053
  71. Shah A, O'Neill J, Feldman SR. Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series. J Drugs Dermatol. 2010 Dec; 9(12):1491-4.
    View in: PubMed
    Score: 0.053
  72. Sagransky MJ, Yentzer BA, Williams LL, Clark AR, Taylor SL, Feldman SR. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010 Dec; 146(12):1428-30.
    View in: PubMed
    Score: 0.053
  73. Feldman SR. Psoralen plus ultraviolet A light phototherapy effectiveness. J Am Acad Dermatol. 2010 Oct; 63(4):718.
    View in: PubMed
    Score: 0.053
  74. Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E, Feldman SR. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis. 2010 Oct; 86(4):208-13.
    View in: PubMed
    Score: 0.053
  75. Alikhan A, Daly M, Wu J, Balkrishnan R, Feldman SR. Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States. J Dermatolog Treat. 2010 Sep; 21(5):276-81.
    View in: PubMed
    Score: 0.052
  76. Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Fleischer AB, Feldman SR. Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. Cutis. 2010 Aug; 86(2):103-8.
    View in: PubMed
    Score: 0.052
  77. Uhlenhake EE, Feldman SR. Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis. Expert Opin Biol Ther. 2010 Jul; 10(7):1105-12.
    View in: PubMed
    Score: 0.052
  78. Lott R, Taylor SL, O'Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol. 2010 Jun; 9(2):160-6.
    View in: PubMed
    Score: 0.051
  79. Feldman SR. Placebo response? Psychosom Med. 2010 Jun; 72(5):505; author reply 505-6.
    View in: PubMed
    Score: 0.051
  80. Balkrishnan R, Bhosle MJ, Camacho F, Fleischer AB, Feldman SR. Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey. J Dermatolog Treat. 2010 May; 21(3):193-200.
    View in: PubMed
    Score: 0.051
  81. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol. 2010 Mar; 9(1):59-63.
    View in: PubMed
    Score: 0.051
  82. Uhlenhake EE, Kurkowski D, Feldman SR. Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations. J Dermatolog Treat. 2010 Jan; 21(1):6-12.
    View in: PubMed
    Score: 0.050
  83. Nolan BV, Feldman SR. Adherence, the fourth dimension in the geometry of dermatological treatment. Arch Dermatol. 2009 Nov; 145(11):1319-21.
    View in: PubMed
    Score: 0.049
  84. Dubina MI, O'Neill JL, Feldman SR. Effect of patient satisfaction on outcomes of care. Expert Rev Pharmacoecon Outcomes Res. 2009 Oct; 9(5):393-5.
    View in: PubMed
    Score: 0.049
  85. Zivkovich AH, Feldman SR. Are ointments better than other vehicles for corticosteroid treatment of psoriasis? J Drugs Dermatol. 2009 Jun; 8(6):570-2.
    View in: PubMed
    Score: 0.048
  86. Yentzer B, Hick J, Williams L, Inabinet R, Wilson R, Camacho FT, Russell GB, Feldman SR. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses. Arch Dermatol. 2009 Feb; 145(2):203-5.
    View in: PubMed
    Score: 0.047
  87. Alikhan A, Sodhi N, Feldman SR. Equating topical treatment of severe psoriasis to keeping money in a mattress. J Dermatolog Treat. 2009; 20(1):1-2.
    View in: PubMed
    Score: 0.047
  88. Feldman SR. Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis? J Dermatolog Treat. 2009; 20(6):317-8.
    View in: PubMed
    Score: 0.047
  89. Feldman SR. Radiofrequency heating for striae: does it work? J Dermatolog Treat. 2009; 20(6):318.
    View in: PubMed
    Score: 0.047
  90. Feldman S, Pearce DJ, Williford PM. Surgical decision making for basal-cell carcinoma of the face. Lancet Oncol. 2008 Dec; 9(12):1119-20.
    View in: PubMed
    Score: 0.046
  91. Chisolm SS, Taylor SL, Balkrishnan R, Feldman SR. Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol. 2008 Oct; 59(4):677-83.
    View in: PubMed
    Score: 0.045
  92. Conde JF, Kaur M, Fleischer AB, Tusa MG, Camacho F, Feldman SR. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis. 2008 May; 81(5):435-41.
    View in: PubMed
    Score: 0.044
  93. Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol. 2008 Jan; 58(1):125-35.
    View in: PubMed
    Score: 0.043
  94. Feldman SR. Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial. Cutis. 2007 Nov; 80(5 Suppl):20-8.
    View in: PubMed
    Score: 0.043
  95. Feldman SR. Misunderstandings. J Dermatolog Treat. 2007; 18(1):4.
    View in: PubMed
    Score: 0.041
  96. Feldman SR, Vallejos QM, Whalley LE, Quandt SA, Brooks T, Cabral G, Earp P, Bischoff W, Arcury TA. Blistering eruption in a Latino migrant farmworker. J Agromedicine. 2007; 12(4):81-5.
    View in: PubMed
    Score: 0.041
  97. Kaur M, Oliver B, Hu J, Feldman SR. Nonlaser UVB-targeted phototherapy treatment of psoriasis. Cutis. 2006 Sep; 78(3):200-3.
    View in: PubMed
    Score: 0.040
  98. Warino L, Balkrishnan R, Feldman SR. Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol. 2006 Jun; 5(6):527-32.
    View in: PubMed
    Score: 0.039
  99. Kirkland CR, Yelverton CB, Fleischer AB, Camacho FT, Feldman SR. Gel vehicles are not inherently more irritating than creams. J Drugs Dermatol. 2006 Mar; 5(3):269-72.
    View in: PubMed
    Score: 0.038
  100. Callender VD, Young CM, Haverstock CL, Carroll CL, Feldman SR. An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis. Cutis. 2005 Jun; 75(6):317-21.
    View in: PubMed
    Score: 0.036
  101. Kulkarni AS, Balkrishnan R, Richmond D, Pearce DJ, Feldman SR. Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States. J Am Acad Dermatol. 2005 Jan; 52(1):27-31.
    View in: PubMed
    Score: 0.035
  102. Feldman SR, Nijsten T, Margolis DJ, Rolstad T. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing. J Am Acad Dermatol. 2005 Jan; 52(1):140-1.
    View in: PubMed
    Score: 0.035
  103. Carroll CL, Clarke J, Camacho F, Balkrishnan R, Feldman SR. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch Dermatol. 2005 Jan; 141(1):43-6.
    View in: PubMed
    Score: 0.035
  104. Su J, Pearce DJ, Feldman SR. The role of commercial tanning beds and ultraviolet A light in the treatment of psoriasis. J Dermatolog Treat. 2005; 16(5-6):324-6.
    View in: PubMed
    Score: 0.035
  105. Feldman S. Modest innovations in psoriasis treatment? J Dermatolog Treat. 2003 Dec; 14(4):198-9.
    View in: PubMed
    Score: 0.033
  106. Balkrishnan R, Gill IK, Vallee JA, Feldman SR. No smoking gun: findings from a national survey of office-based cosmetic surgery adverse event reporting. Dermatol Surg. 2003 Nov; 29(11):1093-9; discussion 1099.
    View in: PubMed
    Score: 0.033
  107. Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB, Feldman SR. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. J Am Acad Dermatol. 2003 Jul; 49(1):79-82.
    View in: PubMed
    Score: 0.032
  108. Krob AH, Fleischer AB, D'Agostino R, Feldman SR. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials. J Cutan Med Surg. 2003 Jul-Aug; 7(4):306-11.
    View in: PubMed
    Score: 0.032
  109. Wilson JK, Al-Suwaidan SN, Krowchuk D, Feldman SR. Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol. 2003 Jan-Feb; 20(1):11-5.
    View in: PubMed
    Score: 0.031
  110. Lebwohl M, Menter A, Koo J, Feldman S. Case studies in severe psoriasis: A clinical strategy. J Dermatolog Treat. 2003; 14 Suppl 2:26-46.
    View in: PubMed
    Score: 0.031
  111. Feldman SR, Mellen BG, Housman TS, Fitzpatrick RE, Geronemus RG, Friedman PM, Vasily DB, Morison WL. Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol. 2002 Jun; 46(6):900-6.
    View in: PubMed
    Score: 0.030
  112. Rodewald EJ, Housman TS, Mellen BG, Feldman SR. Follow-up survey of 308-nm laser treatment of psoriasis. Lasers Surg Med. 2002; 31(3):202-6.
    View in: PubMed
    Score: 0.029
  113. Grada A, Feldman SR, Bragazzi NL, Damiani G. Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review. Dermatol Ther. 2021 03; 34(2):e14833.
    View in: PubMed
    Score: 0.027
  114. Gao JC, Emmerich VK, Feldman S, Strowd LC. Evaluating calcipotriene 0.005% foam for the treatment of plaque psoriasis of the scalp and body in patients aged 12 years and older. Expert Opin Pharmacother. 2021 Apr; 22(5):543-547.
    View in: PubMed
    Score: 0.027
  115. Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M. Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis. Qual Life Res. 2020 Feb; 29(2):369-380.
    View in: PubMed
    Score: 0.025
  116. Baumrin E, Van Voorhees A, Garg A, Feldman SR, Merola JF. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2019 Jul; 81(1):102-110.
    View in: PubMed
    Score: 0.024
  117. Aung-Din D, Heath M, Wechter T, Cline A, Feldman SR, Jorizzo JL. Effectiveness of the Tacrolimus Swish-and-Spit Treatment Regimen in Patients With Geographic Tongue. JAMA Dermatol. 2018 12 01; 154(12):1481-1482.
    View in: PubMed
    Score: 0.023
  118. He A, Feldman SR, Fleischer AB. An assessment of the use of antihistamines in the management of atopic dermatitis. J Am Acad Dermatol. 2018 Jul; 79(1):92-96.
    View in: PubMed
    Score: 0.022
  119. Rajabi-Estarabadi A, Hasanzadeh H, Taheri A, Feldman SR, Firooz A. The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis. J Dermatolog Treat. 2018 Mar; 29(2):111-115.
    View in: PubMed
    Score: 0.021
  120. Papp KA, Krueger JG, Feldman SR, Langley RG, Thaci D, Torii H, Tyring S, Wolk R, Gardner A, Mebus C, Tan H, Luo Y, Gupta P, Mallbris L, Tatulych S. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study. J Am Acad Dermatol. 2016 May; 74(5):841-50.
    View in: PubMed
    Score: 0.019
  121. Ahn CS, Dothard EH, Garner ML, Feldman SR, Huang WW. To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2015 Sep; 73(3):420-8.e1.
    View in: PubMed
    Score: 0.018
  122. Hoover WD, Jorizzo JL, Clark AR, Feldman SR, Holbrook J, Huang KE. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis. Cutis. 2014 Nov; 94(5):255-9.
    View in: PubMed
    Score: 0.017
  123. Kim IH, West CE, Kwatra SG, Feldman SR, O'Neill JL. Comparative efficacy of biologics in psoriasis: a review. Am J Clin Dermatol. 2012 Dec 01; 13(6):365-74.
    View in: PubMed
    Score: 0.015
  124. Patel P, Lin HC, Feldman SR, Fleischer AB, Nahata MC, Balkrishnan R. Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States. J Drugs Dermatol. 2011 Jul; 10(7):766-71.
    View in: PubMed
    Score: 0.014
  125. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Leonardi CL, Lim HW, Van Voorhees AS, Beutner KR, Ryan C, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011 Jul; 65(1):137-74.
    View in: PubMed
    Score: 0.013
  126. Langley RG, Feldman SR, Han C, Schenkel B, Szapary P, Hsu MC, Ortonne JP, Gordon KB, Kimball AB. Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol. 2010 Sep; 63(3):457-65.
    View in: PubMed
    Score: 0.013
  127. Bansback N, Sizto S, Sun H, Feldman S, Willian MK, Anis A. Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis. Dermatology. 2009; 219(3):209-18.
    View in: PubMed
    Score: 0.012
  128. Revicki DA, Menter A, Feldman S, Kimel M, Harnam N, Willian MK. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study. Health Qual Life Outcomes. 2008 Oct 02; 6:75.
    View in: PubMed
    Score: 0.011
  129. Price J, Bhosle M, Feldman SR, Balkrishnan R. Outcomes associated with the use of biologic agents in moderate to severe psoriasis. J Drugs Dermatol. 2007 Mar; 6(3):259-67.
    View in: PubMed
    Score: 0.010
  130. Menter A, Feldman SR, Weinstein GD, Papp K, Evans R, Guzzo C, Li S, Dooley LT, Arnold C, Gottlieb AB. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2007 Jan; 56(1):31.e1-15.
    View in: PubMed
    Score: 0.010
  131. Lebwohl M, Freeman A, Chapman MS, Feldman S, Hartle J, Henning A. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Arch Dermatol. 2005 Sep; 141(9):1154.
    View in: PubMed
    Score: 0.009
  132. Lowe N, Feldman SR, Sherer D, Weiss J, Shavin JS, Lin YL, Foley V, Soto P. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. J Dermatolog Treat. 2005 Aug; 16(3):158-64.
    View in: PubMed
    Score: 0.009
  133. Nijsten T, Margolis DJ, Feldman SR, Rolstad T, Stern RS. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol. 2005 Mar; 52(3 Pt 1):434-44.
    View in: PubMed
    Score: 0.009
  134. Gordon KB, Feldman SR, Koo JY, Menter A, Rolstad T, Krueger G. Definitions of measures of effect duration for psoriasis treatments. Arch Dermatol. 2005 Jan; 141(1):82-4.
    View in: PubMed
    Score: 0.009
  135. Housman TS, Norton AB, Feldman SR, Fleischer AB, Simpson EL, Hanifin JM, Antaya RJ. Tacrolimus ointment: utilization patterns in children under age 2 years. Dermatol Online J. 2004 Jul 15; 10(1):2.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.